DH DEFINITIVE HEALTHCARE CORP revenue, earnings and financials

For the quarter ended June 30, 2026, DEFINITIVE HEALTHCARE CORP reported revenue of $55.2M (down 9.1% from a year earlier), net income of −$5.42M and diluted EPS of −$0.05; over the last four quarters revenue was $233M and net income −$168M; for the fiscal year ended December 2025 revenue was $242M, down 4.2% on the year before.

DH annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $242M, gross profit $183M, operating income −$224M, net income −$139M (margin -57.5%), EPS −$1.30
• Fiscal year ended Dec 2024: revenue $252M, gross profit $197M, operating income −$711M, net income −$413M (margin -163.8%), EPS −$3.54
• Fiscal year ended Dec 2023: revenue $251M, gross profit $204M, operating income −$330M, net income −$202M (margin -80.5%), EPS −$1.79
• Fiscal year ended Dec 2022: revenue $223M, gross profit $180M, operating income −$44.0M, net income −$7.22M (margin -3.2%), EPS −$0.07
• Fiscal year ended Dec 2021: revenue $166M, gross profit $125M, operating income −$27.3M, net income −$17.8M (margin -10.7%), EPS −$0.19

DH quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $55.2M (down 9.1% year over year), net income −$5.42M, EPS −$0.05
• Quarter ended Mar 31, 2026: revenue $55.9M (down 5.5% year over year), net income −$139M, EPS −$1.32
• Quarter ended Dec 31, 2025 (from the annual report): revenue $61.5M (down 1.2% year over year), net income −$9.32M, EPS −$0.14
• Quarter ended Sep 30, 2025: revenue $60.0M (down 4.2% year over year), net income −$14.8M, EPS −$0.14
• Quarter ended Jun 30, 2025: revenue $60.8M (down 4.7% year over year), net income −$7.55M, EPS −$0.07
• Quarter ended Mar 31, 2025: revenue $59.2M (down 6.8% year over year), net income −$107M, EPS −$0.95
• Quarter ended Dec 31, 2024 (from the annual report): revenue $62.3M (down 5.5% year over year), net income −$59.1M, EPS −$0.53
• Quarter ended Sep 30, 2024: revenue $62.7M (down 4.0% year over year), net income −$131M, EPS −$1.12
• Quarter ended Jun 30, 2024: revenue $63.7M (up 4.6% year over year), net income −$214M, EPS −$1.81
• Quarter ended Mar 31, 2024: revenue $63.5M (up 7.2% year over year), net income −$9.52M, EPS −$0.08
• Quarter ended Dec 31, 2023 (from the annual report): revenue $65.9M (up 8.8% year over year), net income −$10.2M, EPS −$0.10
• Quarter ended Sep 30, 2023: revenue $65.3M (up 13.8% year over year), net income −$172M, EPS −$1.50
• Quarter ended Jun 30, 2023: revenue $61.0M (up 11.7% year over year), net income −$8.57M, EPS −$0.08
• Quarter ended Mar 31, 2023: revenue $59.2M (up 18.1% year over year), net income −$12.1M, EPS −$0.11
• Quarter ended Dec 31, 2022: revenue $60.6M (up 30.8% year over year), net income $9.87M, EPS $0.06
• Quarter ended Sep 30, 2022: revenue $57.4M (up 33.2% year over year), net income −$3.02M, EPS −$0.03
• Quarter ended Jun 30, 2022: revenue $54.5M (up 37.0% year over year), net income −$5.49M, EPS −$0.06
• Quarter ended Mar 31, 2022: revenue $50.1M (up 35.7% year over year), net income −$8.58M, EPS −$0.09
• Quarter ended Dec 31, 2021: revenue $46.3M, net income −$9.86M, EPS −$0.11
• Quarter ended Sep 30, 2021: revenue $43.1M, net income −$7.98M, EPS −$0.09

DH cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $53.8M, share buybacks $49.5M
• Fiscal year ended Dec 2024: operating cash flow $58.2M, share buybacks $22.4M
• Fiscal year ended Dec 2023: operating cash flow $41.2M, share buybacks $0
• Fiscal year ended Dec 2022: operating cash flow $35.6M, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $25.2M, share buybacks n/a

DH balance sheet

• Jun 30, 2026: cash $171M, total assets $497M, total liabilities $309M, shareholders' equity n/a, long-term debt $152M
• Mar 31, 2026: cash $158M, total assets $515M, total liabilities $324M, shareholders' equity n/a, long-term debt $154M
• Dec 31, 2025: cash $164M, total assets $735M, total liabilities $357M, shareholders' equity n/a, long-term debt $156M
• Sep 30, 2025: cash $108M, total assets $756M, total liabilities $366M, shareholders' equity n/a, long-term debt $158M
• Jun 30, 2025: cash $81.0M, total assets $770M, total liabilities $359M, shareholders' equity n/a, long-term debt $160M
• Mar 31, 2025: cash $106M, total assets $809M, total liabilities $373M, shareholders' equity n/a, long-term debt $162M
• Dec 31, 2024: cash $105M, total assets $1.09B, total liabilities $482M, shareholders' equity n/a, long-term debt $229M
• Sep 30, 2024: cash $138M, total assets $1.18B, total liabilities $486M, shareholders' equity n/a, long-term debt $233M

What is DH's revenue?

DEFINITIVE HEALTHCARE CORP reported $233M of revenue over its last four quarters, through June 30, 2026.

Is DH profitable?

No. DEFINITIVE HEALTHCARE CORP lost $168M over the last four quarters.

What is DH's EPS?

Diluted earnings per share over the last four quarters were −$1.65; −$0.05 in the latest quarter.

DH ownership and insider trades · All stocks